Similar articles

• Involvement of brain 5-HT1A receptors in the hypotensive response to urapidil.

  Kolassa N, Beller KD, Sanders KH. Kolassa N, et al. Am J Cardiol. 1989 Aug 15;64(7):7D-10D. doi: 10.1016/0002-9149(89)90688-7. Am J Cardiol. 1989. PMID: 2569265 Review.
• Interaction of urapidil with brain serotonin-1A receptors increases the blood pressure reduction due to peripheral alpha-adrenoceptor inhibition.

  Sanders KH, Beller KD, Bischler P, Kolassa N. Sanders KH, et al. J Hypertens Suppl. 1988 Dec;6(2):S65-8. J Hypertens Suppl. 1988. PMID: 2906703
• The role of serotonin-1A receptor activation and alpha-1 adrenoceptor blockade in the hypotensive effect of 5-methyl-urapidil.

  Mandal AK, Kellar KJ, Gillis RA. Mandal AK, et al. J Pharmacol Exp Ther. 1991 May;257(2):861-9. J Pharmacol Exp Ther. 1991. PMID: 1674536
• Deviating central hypotensive activity of urapidil in the cat.

  van Zwieten PA, Mathy MJ, Thoolen MJ. van Zwieten PA, et al. J Pharm Pharmacol. 1985 Nov;37(11):810-1. doi: 10.1111/j.2042-7158.1985.tb04973.x. J Pharm Pharmacol. 1985. PMID: 2867163
• Pharmacological profile of antihypertensive drugs with serotonin receptor and alpha-adrenoceptor activity.

  van Zwieten PA, Blauw GJ, van Brummelen P. van Zwieten PA, et al. Drugs. 1990;40 Suppl 4:1-8; discussion 28-30. doi: 10.2165/00003495-199000404-00003. Drugs. 1990. PMID: 1982649 Review.